Why COVID Vaccines Are Dream Come True for Central Banks
Paired with the rollout of related surveillance technologies — digital tracking devices, vaccine passports, brain-machine interfaces and planet-wide 5G — COVID vaccines are a critical component of central bankers’ plan to establish a global control grid.
Faced with widespread recalcitrance, health officials like Francis Collins, director of the National Institutes of Health (NIH), have been upping their public relations offensive, including dangling the threat of COVID vaccine mandates.
This is unsurprising coming from a pharma-beholden and conflict-of-interest-riddled health agency like the NIH. But why are financial gurus like Jerome Powell, U.S. Federal Reserve chair — a wealthy lawyer and investment banker — also heavy-handedly making the COVID vaccines the centerpiece of their public prognostications?
In a recent 60 Minutes interview, Powell returned to the COVID jabs again and again, trying to make the case that economic recovery depends on everyone getting vaccinated.
To understand central bankers’ aims, it is important to recognize that COVID has furnished a pretext for deploying waiting-in-the-wings vaccine biotechnologies that differ substantially from the already problematic lab techniques used to create earlier generations of vaccines.
Dazzled by the endless vistas opened up by these technologies, proponents envision a rosy future filled with “programmable ‘smart vaccines’” — concoctions that would permit synthetic biologists to become the puppet masters of human biology.
Nowhere is this intention more apparent than in Moderna’s description of its messenger RNA (mRNA) technology platform. Moderna openly refers to its technology as an “operating system … designed so that it can plug and play interchangeably with different programs.” The company even suggests that the unique mRNA sequences it develops for vaccines be viewed as “apps.”
Mixed public reactions to this dispassionate language propelled Reuters, in February, to publish a fact check claiming that Moderna is referring to operating systems only “in a metaphorical sense, not a literal one.”
However, in a 2017 TEDx talk, Moderna chief medical officer Tal Zaqs’ earnest declaration that “we’re actually hacking the software of life” sounded anything but “metaphorical.” Stating that the genetic instructions transmitted by RNA are “critical information that determines what a cell will actually do,” Zaqs characterized his company’s mission as one of introducing or changing “lines of code” for the purposes of “information therapy.”
Other scientists engaged in “mRNA modifications” agree. However, while describing the approach as “powerful,” “dynamic” and “versatile,” they concede that “many aspects. . . remain elusive.”
Vaccine and drug manufacturers have interpreted the U.S. Food and Drug Administration’s (FDA’s) decisions to grant Emergency Use Authorization to the Moderna and Pfizer COVID vaccines as a signal the FDA “is open to broader use of the previously unproven [mRNA] technology.”
As a result, mRNA-focused companies are attracting billions in new capital. Reuters reported at least 150 mRNA vaccines and therapeutics are currently in development globally.
As pleased as these medical-pharmaceutical players may be to accrue additional funding and prestige, they are far from the sole beneficiaries of the new technologies’ rollout. Circling back to the centralizing aims of the world’s central bankers, British writer David O’Hagan said, “The combination of biocomputing within the body and external silicone-based technology is foundational to the implementation of transhumanism, a new data-driven economic system and complete control.”
O’Hagan quotes former investment banker Catherine Austin Fitts, who has warned from the beginning of the pandemic that COVID vaccines are the equivalent of “human ‘operating systems.’”
Addressing the topic of vaccine passports, author and tech company CEO Naomi Wolf cautioned their implementation would mean “literally the end of human liberty in the West.”
In the operating system framework, it is also clear the vaccines are not a matter of “one [or two] and done.” Pfizer’s CEO has already said not only will a third COVID injection “likely” be needed within 12 months of the two initial injections, but that annual coronavirus vaccines are a distinct possibility.
U.S. government contracts (jointly awarded by the U.S. Department of Health and Human Services and the U.S. Department of Defense) for monthly production of up to 330 million prefilled syringes ominously hint at plans for even more frequent “updates” to the operating system.
Unvaccinated individuals — in the U.S. and globally — likely have many different reasons for wanting to take a pass on COVID injections. Recognizing the vaccines have little to do with medicine or health and much more to do with centralization and control is an important step in pushing back against liberty-suffocating restrictions and central bankers’ vision of an all-powerful on-off switch controlling each person’s participation in the financial system and wider society.